Clinical Trial Update: Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 gene therapy trial for recurrent or progressive brain tumors sponsored by the National Cancer Institute has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Central Nervous System Tumors

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED